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Abstract 
Background: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) 
measured the global prevalence of symptoms of asthma in children. We undertook comprehensive 
analyses addressing risk factors for asthma symptoms in combination, at both the individual and the 
school level, to explore the potential role of reverse causation due to selective avoidance or 
confounding by indication. 
Objective: To explore the role of reverse causation in risk factors of asthma symptoms. 
Methods: We compared two sets of multilevel logistic regression analyses, using (i) individual-level 
exposure data and (ii) school-level average exposure (i.e. prevalence), in two different age groups.  In 
individual-level analyses, reverse causation is a possible concern if individual-level exposure statuses 
were changed as a result of asthma symptoms or diagnosis. School-level analyses may suffer from 
ecologic confounding, but reverse causation is less of a concern because individual changes in 
exposure status as a result of asthma symptoms would only have a small effect on overall school 
exposure levels. 
Results: There were 131,924 children age 6-7 years (2,428 schools, 25 countries) with complete 
exposure, outcome and confounder data. The strongest associations in individual-level analyses 
(fully-adjusted) were for current paracetamol use (odds ratio = 2.06; 95% confidence interval 1.97-
2.16), early life antibiotic use (1.65; 1.58-1.73), and open fire cooking (1.44; 1.26-1.65). In school-
level analyses these risk factors again showed increased risks.  
There were 238,586 adolescents age 13-14 years (2,072 schools, 42 countries) with complete 
exposure, outcome and confounder data. The strongest associations in individual-level analyses 
(fully-adjusted) were for current paracetamol use (1.80; 1.75-1.86), cooking on an open fire (1.32; 
1.22-1.43), and maternal tobacco use (1.23; 1.18-1.27). In school-level analyses these risk factors 
again showed increased risks. 
Conclusions & clinical relevance: These analyses strengthen the potentially causal interpretation of 
previously reported individual-level findings, by providing evidence against reverse causation.  
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Introduction 
Asthma is becoming increasingly important as a childhood disease on a global basis(1). The Global 
Asthma Report 2018 estimated that as many as 339 million people have asthma and that the burden 
of disability is high(2). 
The International Study of Asthma and Allergies in Childhood (ISAAC), using a simple and inexpensive 
standardized methodology(3-5), has documented a wide variation of asthma prevalence in different 
parts of the world(6, 7), and a number of papers have been published addressing the findings for 
individual risk factors, with a several associations observed (see “Variables” below)(8-20). However, 
these risk factors have not previously been considered together within the same analysis, so it is 
possible that some of the observed associations may be at least partially due to confounding by 
other risk factors. 
The current paper represents the first comprehensive analyses to address these risk factors together, 
in order to fill this gap in the current knowledge. We have done this in two ways. Firstly, we have 
conducted a ‘standard’ analysis using the individual level exposure data for each risk factor (e.g. 
maternal smoking). However, for some risk factors the cross-sectional nature of the study means that 
such analyses may be subject to ‘reverse causation’ if individual-level exposure statuses were changed 
as a result of asthma symptoms or diagnosis. This may occur due to selective avoidance (e.g. if the 
child’s mother stops smoking because the child has developed asthma) or ‘confounding by indication’ 
(e.g. if exposures such as paracetamol or antibiotics are taken in response to symptoms which are 
related to the subsequent development of asthma).  
As schools were the level of sampling in ISAAC, we have therefore conducted a second set of analyses 
using the school-level average reported exposure (i.e. the prevalence; rather than the reported 
individual exposure) to each risk factor to attempt to avoid or minimise such biases. School-level 
analyses may suffer from ecologic (community-level) confounding, but reverse causation is perhaps 
less of a concern because individual changes in exposure status as a result of asthma symptoms would 
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only have a small effect on overall school exposure levels. It is therefore of considerable interest to 
compare the individual-level and school-level analyses. 
If reverse causation due to confounding by indication was exerting a major influence on the 
individual-level associations, we would expect the associations to be much reduced at the school-
level. Conversely, if there was reverse causation due to selective avoidance, we would expect a 
stronger association at the school-level, although this could also be due to contextual factors 
operating at the school level. Consistency of findings at the two levels thus provides indirect 
evidence against reverse causation and against strong contextual factors. 
Biases may differ in different parts of the world, for example breast feeding is more strongly 
associated with socioeconomic status in high-income countries than in low and middle income-
countries (21), hence there is a greater potential for confounding by socioeconomic status in the 
former. Therefore we additionally conducted analyses stratified by country-level affluence to 
examine the extent to which associations and biases differed. 
 
  
7 
 
Methods 
Study 
ISAAC Phase Three methods have been described in detail elsewhere,(4) and will be summarized 
briefly here. ISAAC Phase Three is a multi-centre, multi-country, cross-sectional study of two age 
groups of schoolchildren (6-7 year old children and 13-14 year old adolescents) chosen from a 
random sample of schools in a defined geographical area(3, 4).  The Phase Three survey took place in 
2000-2003 and included two standardised questionnaires. The first obtained data on symptoms of 
asthma, rhinoconjunctivitis and eczema, and was identical to that used in Phase One of ISAAC.(6, 22) 
The second, the environmental questionnaire, obtained data on a range of possible risk factors for 
the development of asthma and allergic disorders(8). The questionnaires can be found on the ISAAC 
website (http://isaac.auckland.ac.nz). 
Variables 
We considered the outcome of wheeze in the last 12 months, defined by a positive response to the 
question “Has your child/have you had wheezing or whistling in the chest in the past 12 months?”. In 
many countries in the world we find that most asthma (based on symptoms) has not been diagnosed, 
which is why ISAAC is based on symptoms. The ISAAC symptoms questionnaire validates well against 
doctor-diagnosed asthma(23).  
The environmental questionnaires in the two age groups did not contain identical questions, so it 
was not possible to examine the same set of potential risk factors in each age group. In addition, we 
restricted our analyses to the risk factors which had shown associations with wheeze in the last 12 
months in previous analyses at the individual level. For the younger age group, we included 
paracetamol use in the first year of life and in the past 12 months(8), antibiotic use in the first year of 
life(20), breast feeding(9), cat in the home in the first year of life(11), regular contact with farm 
animals in the first year of life(12), truck traffic(10), fast food consumption(13), television 
viewing(15), parental smoking(16), cooking on an open fire(19), and birth weight(17). For the older 
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age group, we included truck traffic(10), fast food consumption(13), television viewing(15), parental 
smoking(16), paracetamol use in the past 12 months(24), and open fire cooking(19). 
Most of the above risk factors were parameterised as binary variables from “yes/no” questions in the 
environmental questionnaire. The exceptions were: paracetamol use in the past 12 months (at least 
once per month vs. less than once per month), truck traffic (seldom or more frequently vs. never), 
fast food consumption (once per week or more vs. less than once per week), television viewing (at 
least 1 hour per day vs. less than 1 hour per day), and birth weight (less than 2.5 kg vs. at least 2.5 
kg). Full definitions are in Table S1, Supporting Material. 
Sex was self-reported as male/female and the highest level of maternal education was recorded as 
primary, secondary, tertiary or missing/not stated.  
Gross National Income (GNI) as of 2002 was obtained from the World Bank website(25) where 
available, with gaps filled by the CIA World Factbook(26). Countries were classified as ‘affluent’ or 
‘non-affluent’ using a 2001 GNI value of US$9,205 per capita as a cut-off, which separates high-
income countries from low and middle-income countries(27). 
Statistical analyses 
To be included in the analysis for a particular age-group, centres had to include at least 1,000 
individuals and to have a response rate of >60% for children and >70% for adolescents. Analyses were 
conducted separately in the two age groups. Within each age group, schools with fewer than 10 
individuals were excluded from the analysis. 
All analyses were conducted using mixed effect (multilevel) logistic regression models. The four-level 
hierarchical nature of the data (individuals [level 1], schools [level 2], centres [level 3] and countries 
[level 4]) was acknowledged by allowing random intercepts at levels 2, 3 and 4 in individual-level 
models and by including random intercepts at levels 3 and 4 in school-level models. Centres were self-
selected, whereas schools were randomly sampled within centres, making school the preferred level 
of analysis. Sex and maternal education were adjusted for as individual-level confounders in all models. 
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Three different modelling approaches were used: i) individual-level, ii) school-level and iii) hybrid fixed 
effects(28). However, results from the hybrid fixed effect models were very similar to those from the 
individual-level and school-level models, so they are not discussed further. 
Individual-level models related the individual-level outcome to each individual-level risk factor within 
schools. School-level models related the individual-level outcome to the school-level average exposure 
(i.e. prevalence) of each risk factor. In these models the estimated OR corresponding to the school-
level prevalence of the risk factor can be interpreted as the effect on the individual outcome of 
attending a school where all children are exposed compared to attending a school where no-one is 
exposed.  
Within each approach, models were fitted for: i) each exposure of interest using the sub-sample who 
had data present for wheeze, sex, maternal education and the given exposure (the “maximum 
sample”), ii) each exposure of interest using the sub-sample who had data present for wheeze, sex, 
maternal education and all exposures of interest (the “common sample”), and iii) each exposure of 
interest mutually adjusted using the sub-sample who had data present for wheeze, sex, maternal 
education and all exposures of interest (the “common sample”).  
The extent of collinearity in the mutually adjusted models was examined by comparing the standard 
errors in the mutually adjusted model and the minimally adjusted model fitted to the same sub-
sample(29). There was no evidence of substantial collinearity. 
Additionally, we ran the fully adjusted analyses separately for ‘affluent’ and ‘non-affluent’ countries. 
We then separately tested for effect modification of each risk factor by country-level affluence. 
Analyses were conducted using Stata version 14(30). 
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Results 
6-7 year olds 
The 6-7 year old participants included 221,280 children from 75 centres which met the initial data 
quality criteria (at least 1,000 children and a response rate of >60%). Of these, 212,480 children (from 
2,903 schools, 75 centres, 32 countries) were from schools with at least 10 children and had data 
present for wheeze, sex, maternal education and at least one of the exposures of interest so 
contributed to the analyses for one or more exposures (the “maximum sample”), with 131,924 children 
(from 2,428 schools, 64 centres, 25 countries) having data present for all analysis variables (the 
“common sample”). See the data flowchart (Fig. 1) for further details. Individual- and school-level 
summary statistics are presented in Table S2 for the maximum sample and in Table 1 for the common 
sample. 
Minimally adjusted associations in the common sample were broadly similar to those in the 
maximum sample (Tables 2 and S3). The strongest associations in the fully-adjusted individual-level 
analyses were for current paracetamol use (OR=2.06, 95%CI 1.97-2.16), antibiotic use in the first year 
of life (1.65; 1.58-1.73), and open fire cooking (1.44; 1.26-1.65) (Table 2).  
In the fully-adjusted school-level analyses the associations for current paracetamol use (1.58; 1.18-
2.10), early life antibiotic use (1.38; 1.07-1.78) and open fire cooking (2.02; 1.16-3.50) were 
maintained (Table 2). Stronger associations were observed at the school-level compared with the 
individual-level for low birthweight (2.13; 1.39-3.25 compared to 1.12; 1.05-1.21), maternal tobacco 
use (1.83; 1.36-2.47 compared to 1.20; 1.14-1.27), fast food consumption (1.68; 1.37-2.06 compared 
to 1.07; 1.03-1.12), and early life farm animal exposure (1.36; 1.00-1.85 compared to 1.12; 1.06-
1.20). An association was seen at the school-level only for television viewing (1.80; 1.37-2.37 
compared to 1.04; 0.99-1.10) (Table 2). 
In the analyses stratified by country-level affluence (Tables S4-S5) there was strong evidence 
(p<0.001) of effect modification at the individual-level for early life exposure to cats (1.36; 1.26-1.48 
in non-affluent countries vs. 1.09; 1.00-1.18 in affluent countries), early life exposure to farm animals 
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(1.23; 1.14-1.33 vs. 0.96; 0.87-1.06), and current paracetamol use (1.89; 1.79-2.01 vs. 2.38; 2.21-
2.56) (Tables S5).  
When using the school-level prevalence (Table S5) there was again some evidence (p=0.04) of effect 
modification of current paracetamol use (1.31; 0. 89-1.92 in non-affluent countries vs. 2.32; 1.52-
3.55 in affluent countries). However, there was little evidence of a difference between affluent and 
non-affluent countries for the associations of wheeze with cat and farm animal exposure in the first 
year of life. Several risk factors showed greater effect modification in the school-level analysis than in 
the individual-level analysis: maternal tobacco (3.30; 1.87-5.83 in non-affluent countries vs. 1.49; 
1.06-2.10 in affluent countries in the school-level analysis), antibiotics in the first year of life (1.13; 
0.80-1.61 vs. 1.77; 1.22-2.55), and paracetamol use in the first year of life (0.90; 0.63-1.29 vs. 1.30; 
0.88-1.93). 
13-14 year olds 
The 13-14 year old participants included 362,048 adolescents from 122 centres which met the initial 
data quality criteria (at least 1,000 adolescents and a response rate of >70%). Of these 350,915 
adolescents (from 2,511 schools, 122 centres, 54 countries) were from schools with at least 10 
adolescents and had data present for wheeze, sex, maternal education and at least one of the 
exposures of interest so contributed to the analyses for one or more exposures (the “maximum 
sample”), with 238,586 adolescents (from 2,072 schools, 99 centres, 42 countries) having data present 
for all analysis variables (the “common sample”). See the data flowchart (Fig. 2) for further details. 
Individual- and school-level summary statistics are presented in Table S2 for the maximum sample and 
in Table 1 for the common sample. 
Minimally adjusted associations in the common sample were broadly similar to those in the 
maximum sample (Tables 2 and S3). The strongest associations in the fully-adjusted individual-level 
analyses were for current paracetamol use (1.80; 1.75-1.86), cooking on an open fire (1.32; 1.22-
1.43), and maternal tobacco use (1.23; 1.18-1.27) (Table 2).  
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In the fully-adjusted school-level analyses the association for current paracetamol use (2.31; 1.71-
3.12) and maternal tobacco use (2.51; 1. 74-3.61) were maintained. Although the evidence for an 
association with cooking on an open fire was reduced, the point estimate was comparable to that in 
the individual-level analysis (1.28; 0.85-1.94) (Table 2). An association was also observed at the 
school-level (but not the individual level) for television viewing (2.01; 1.36-2.96). At the individual-
level there was an association with paternal tobacco use (1.12; 1.08-1.15), but this was in the other 
direction at the school-level (0.51; 0.37-0.70). 
In the analyses stratified by country-level affluence (Tables S4-S5) there was evidence (p<0.001) at 
the individual-level that paracetamol use in the last 12 months was more strongly associated with 
wheeze in affluent countries (1.97; 1.85-2.09) than non-affluent (1.75; 1.69-1.82) (Table S4). There 
was no evidence of effect modification at the school-level (Table S5). 
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Discussion 
A number of papers have been published describing the association of asthma symptoms with 
individual-level risk factors in ISAAC Phase Three(8-20). Here, we present the first comprehensive 
analyses to address these risk factors together in a multilevel framework and compare the individual-
level and school-level findings to assess the possibility of various types of bias and confounding.   
The associations we present here at the individual-level (Table 2) generally confirm the results for 
recent wheeze in published ISAAC papers. However, the ORs do not correspond exactly with previous 
publications due to the following differences in analytical approach. Firstly, the ISAAC survey 
methodology involved cluster sampling (sampling schools, then selecting all children of the 
appropriate age within each selected school). In previous publications no adjustment was made for 
within-school clustering of risk factors. In our multilevel models, inclusion of school as a random 
intercept adjusts more formally for intra-class correlation of both symptoms and exposures. This is a 
strength of the multilevel modelling approach. 
Secondly, previous ISAAC Phase Three publications have adjusted for sex but not for socioeconomic 
status at the individual-level, whereas we included individual-level maternal education as a 
socioeconomic indicator in all models. Although maternal education is problematic to interpret as a 
socioeconomic indicator across diverse study centres from different countries and cultures, it is more 
likely to be valid for adjustment of socioeconomic confounding within local communities, such as 
school catchment areas, which is how it is used in our multi-level analyses. 
Thirdly, previous ISAAC publications have adjusted for selected confounders (with a different set for 
each analysis), whereas we took a more comprehensive and harmonised approach in constructing our 
fully adjusted model. Comparison between the minimally adjusted and fully adjusted results in Table 
2 confirms that the associations of wheeze with each risk factor are mutually independent, although 
in general there is some attenuation of the effects when all covariates are included. Some factors (e.g. 
paracetamol use in the first year of life) reduced markedly after confounder adjustment, indicating the 
possibility of residual confounding due to unmeasured confounders. Breastfeeding (in the younger 
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children) and television viewing (in each age group) were the only individual-level risk factors which 
became non-significant after mutual adjustment, though the estimated associations in the minimally 
adjusted models were limited in magnitude prior to further adjustment.  
A potential drawback of including multiple variables in a single model is a reduced sample size due to 
missing covariate data. About one-third of the 6-7-year-olds and about one-quarter of the 13-14-year-
olds were excluded from the fully adjusted model due to incomplete risk factor information. However, 
comparison of results from the maximum sample with those from the common sample show that 
findings were generally very similar for the subset of respondents with complete covariate data, 
suggesting that valid conclusions can be drawn from the “common sample” dataset.  
It should also be noted that, whilst early life exposures are less prone to reverse causality than current 
exposures, recall errors (which may be biased with respect to disease status) are perhaps more likely 
to have affected early childhood exposures in an interview conducted when the child was 6-7 years 
old. 
An innovative feature of this paper is the presentation of associations of school-level prevalence of risk 
factors with individual-level wheeze. This type of population-level analysis is potentially vulnerable to 
the “ecological fallacy”,(31, 32) but this concept has several components, of which only one (ecological 
or population-level confounding) applies in our study. We avoid other forms of ecological fallacy 
because the population-level exposure (school-level prevalence of each risk factor) was derived by 
aggregating individual-level data, so the exposure measure relates directly to the schools actually 
participating in the study (not, for instance, a city-wide or national average) and to the children for 
whom questionnaire data were returned (not, for instance, children of a different age or social group 
in the same area). We regard these as strengths of the multilevel analytical approach. 
The school-level associations shown in Table 2 generally maintained their direction on mutual 
adjustment, but the magnitude of the ORs (comparing the minimally adjusted and fully adjusted 
results) were less stable than the corresponding individual-level associations (also in Table 2). 
Nevertheless, in the younger age group, significant school-level associations were observed in the fully 
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adjusted model with low birthweight, antibiotics in infancy, farm animal exposure in the first year, 
frequent fast-food and television exposure, maternal smoking (but not paternal smoking) and current 
paracetamol use (but not paracetamol use in first year of life). In the older age group, significant 
school-level associations were also observed with television viewing, maternal smoking and current 
paracetamol use. 
The observed consistency of findings at the two levels provides indirect evidence against reverse 
causation and against strong contextual factors. Furthermore, since the spectrum of unmeasured 
confounders is likely to be different at the individual and population levels, consistency of results 
between the two levels provides additional reassurance against unmeasured confounding. Therefore, 
on both counts, cross-level consistency strengthens the evidence for a causal relationship at the 
individual level. 
Such cross-level comparisons (Table 2) show a close similarity in ORs at the individual-level and school-
level for current paracetamol exposure and wheeze in each age group. This is of particular interest as 
a causal interpretation of this association has been disputed, due to the possibility of reverse causation 
(due to confounding by indication for paracetamol use and wheezing in infancy, or due to aspirin 
avoidance by older children with asthma or their families).   
ISAAC Phase Three findings for paracetamol in the first year of life have also been debated.(33) At the 
individual level in the present study we found an OR of 1.75 for paracetamol use in the first year of 
life, which reduced to 1.33 after adjusting for other risk factors; this is similar to the findings from the 
original report(8), which had ORs of 1.77 and 1.46 respectively. It has been suggested that this finding 
may be due to either residual confounding (given that more than one-half of the excess risk has 
disappeared after adjustment for known confounders), or due to confounding by indication(33). This 
viewpoint is perhaps supported by the findings from our school-level analyses, where the minimally 
adjusted association with paracetamol use in the first year of life (OR = 1.42) disappears on adjustment 
for other risk factors (OR = 1.01). 
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Another risk factor which might be prone to reverse causation (due to pet avoidance in allergic 
families) is cat exposure in infancy. Here, the school-level association is somewhat stronger than the 
individual-level association in the minimally adjusted models, as would be predicted from avoidance 
bias. However, after full adjustment the estimated associations are very similar. 
In the older age group we found associations with paternal tobacco smoking which differed in direction 
between the individual- and school-level analyses. This was a surprising finding which we have been 
unable to satisfactorily explain. 
Finally, stratified analyses identified some risk factors whose effects seemed to differ by country-level 
affluence (Tables S5-S7, Supporting Material). In the younger age group, current paracetamol use was 
consistently (i.e. in both individual- and school-level analyses) found to be a stronger risk factor for 
wheeze in affluent countries relative to non-affluent countries. Cat and farm animal exposure in the 
first year of life were found to be stronger risk factors in non-affluent countries (where there is perhaps 
less avoidance bias) in the individual-level analysis. In the school-level analysis the affluence level-
specific associations similarly differed, though there was not statistical evidence for effect 
modification. In the older age group, current paracetamol use was again found to be a stronger risk 
factor for wheeze in affluent countries relative to non-affluent countries, though only in the individual-
level analysis. 
In conclusion, these multilevel analyses generally confirm previously reported child-level findings for 
wheeze in ISAAC but, importantly, they provide additional evidence in favour of direct (rather than 
reverse) causation. This is the first comprehensive analysis of school-level associations, which may be 
particularly relevant to public health policies, which aim to prevent asthma symptoms by modifying 
environment, lifestyle or medication use among whole communities, rather than individual children or 
their families.  
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Tables 
 
Table 1: Summary statistics for variables and their prevalence in subjects who had data present for wheeze, sex, maternal education and all exposures of interest 
(the “common sample”). 
Age group Variable 
Individual-level (n = 131,924)  School-level  (n = 2,428) 
Prevalence (%)  Median prevalence (%) Prevalence IQR (%) 
6-7 years 
Wheeze in the last 12 months 9.8  9.2 (4.7, 15.3) 
Low birthweight 8.1  6.1 (2.6, 10.7) 
Paracetamol (1st year) 65.4  70.6 (56.3, 83.9) 
Antibiotics (1st year) 56.2  57.6 (47.1, 66.0) 
Breastfed ever 81.3  85.2 (74.7, 93.7) 
Cat (1st year) 11.5  9.1 (3.8, 19.0) 
Farm animals (1st year) 10.2  9.1 (3.9, 16.7) 
Truck traffic (current) 79.2  84.5 (75.0, 91.3) 
Fast food (current) 39.9  31.6 (16.7, 50.0) 
Television (current) 79.8  84.4 (73.9, 91.6) 
Paternal tobacco (current) 32.3  34.4 (20.2, 48.3) 
Maternal tobacco (current) 15.3  14.2 (2.1, 30.7) 
Paracetamol (current) 18.3  14.7 (6.4, 28.0) 
Open fire cooking (current) 2.0  0.0 (0.0, 1.7) 
Age group Variable 
Individual-level (n = 238,586)  School-level (n = 2,072) 
Prevalence (%)  Median prevalence (%) Prevalence IQR (%) 
13-14 years 
Wheeze in the last 12 months 10.6  9.8 (5.0, 15.5) 
Truck traffic (current) 83.2  87.3 (79.5, 92.9) 
Fast food (current) 53.6  52.8 (38.9, 67.9) 
Television (current) 85.6  90.5 (81.7, 94.8) 
Paternal tobacco (current) 38.3  37.3 (23.5, 49.4) 
Maternal tobacco (current) 18.1  18.6 (3.4, 35.6) 
Paracetamol (current) 26.7  29.4 (17.3, 41.3) 
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Open fire cooking (current) 5.2  0.7 (0.0, 3.0) 
IQR = interquartile range.
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Table 2. Effects of individual- and school-level exposures on wheeze in the last 12 months for subjects who had data present for wheeze, sex, maternal education 
and all exposures of interest (the “common sample”). Mixed logistic regression models with random intercepts at the school, centre and country levels. 
Age group Exposure 
Individual-level exposure  School-level exposure 
Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
 Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
6-7 years 
(n = 131,924) 
Low birthweight 1.20 (1.12, 1.29) 1.12 (1.05, 1.21)  2.43 (1.60, 3.69) 2.13 (1.39, 3.25) 
Paracetamol (1st year) 1.75 (1.67, 1.84) 1.33 (1.27, 1.40)  1.42 (1.11, 1.82) 1.01 (0.78, 1.32) 
Antibiotics (1st year) 1.90 (1.83, 1.98) 1.65 (1.58, 1.73)  1.49 (1.17, 1.90) 1.38 (1.07, 1.78) 
Breastfed ever 0.91 (0.87, 0.96) 0.96 (0.91, 1.01)  0.80 (0.60, 1.09) 1.11 (0.82, 1.50) 
Cat (1st year) 1.29 (1.22, 1.37) 1.22 (1.15, 1.29)  1.44 (1.06, 1.94) 1.20 (0.88, 1.65) 
Farm animals (1st year) 1.24 (1.16, 1.31) 1.12 (1.06, 1.20)  1.47 (1.11, 1.94) 1.36 (1.00, 1.85) 
Truck traffic (current) 1.24 (1.17, 1.30) 1.17 (1.11, 1.23)  1.25 (0.97, 1.62) 1.04 (0.81, 1.33) 
Fast food (current) 1.14 (1.09, 1.19) 1.07 (1.03, 1.12)  1.80 (1.47, 2.20) 1.68 (1.37, 2.06) 
Television (current) 1.11 (1.06, 1.17) 1.04 (0.99, 1.10)  2.08 (1.61, 2.69) 1.80 (1.37, 2.37) 
Paternal tobacco (current) 1.20 (1.15, 1.25) 1.12 (1.07, 1.17)  1.51 (1.20, 1.89) 0.83 (0.63, 1.08) 
Maternal tobacco (current) 1.32 (1.25, 1.38) 1.20 (1.14, 1.27)  2.22 (1.72, 2.87) 1.83 (1.36, 2.47) 
Paracetamol (current) 2.35 (2.24, 2.46) 2.06 (1.97, 2.16)  2.05 (1.55, 2.71) 1.58 (1.18, 2.10) 
Open fire cooking (current) 1.44 (1.26, 1.65) 1.44 (1.26, 1.65)  1.95 (1.15, 3.29) 2.02 (1.16, 3.50) 
Age group Exposure 
Individual-level exposure  School-level exposure 
Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
 Minimally adjustedA 
OR (95% CI) 
Fully adjustedB  
OR (95% CI) 
13-14 years 
(n = 238,586) 
Truck traffic (current) 1.20 (1.15, 1.25) 1.16 (1.12, 1.21)  1.52 (1.09, 2.11) 1.28 (0.92, 1.79) 
Fast food (current) 1.11 (1.08, 1.15) 1.07 (1.04, 1.10)  1.36 (1.09, 1.71) 1.21 (0.96, 1.51) 
Television (current) 1.06 (1.01, 1.11) 1.02 (0.97, 1.07)  2.29 (1.56, 3.37) 2.01 (1.36, 2.96) 
Paternal tobacco (current) 1.19 (1.16, 1.23) 1.12 (1.08, 1.15)  0.85 (0.63, 1.13) 0.51 (0.37, 0.70) 
Maternal tobacco (current) 1.30 (1.26, 1.35) 1.23 (1.18, 1.27)  1.94 (1.39, 2.70) 2.51 (1.74, 3.61) 
Paracetamol (current) 1.83 (1.78, 1.89) 1.80 (1.75, 1.86)  2.43 (1.79, 3.29) 2.31 (1.71, 3.12) 
Open fire cooking (current) 1.31 (1.21, 1.41) 1.32 (1.22, 1.43)  0.98 (0.65, 1.48) 1.28 (0.85, 1.94) 
AAdjusted for sex and mothers level of education. BAdditionally adjusted for all other variables in the table.  
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Figure legends 
 
Fig. 1. Data flowchart for 6-7 year old children. 
 
 
Fig. 2. Data flowchart for 13-14 year old adolescents. 
 
 
 
 
